Cellavitora-8 therapy may help to restore organ cells damage

A recent clinical study showed that the oral autologous bone marrow stem cell activator can regenerate a number of degenerative cell functions and restore the body to its normal status. The results were presented at the recent annual conference on interstitial stem cells in Singapore.
Of the 426 receptors treated, after 6 months we found a significant increase of blood flow stem cells and a significant improvement in the body. Several of the patient's symptoms were alleviated. The study was carried out by Daniel DeBolci, a professor at The University of Hanman.